All funds

Fondsfinans Global Helse B

Equity fund

1 year

Globe

USA

Largest region

Medium

Risk

Annual costs

Morningstar

 

Partial 

Sustainability

Development

Last 5 years
( ann.)

Details

  • Fondsfinans Global Helse er et aktivt forvaltet globalt aksjefond som investerer i store og likvide selskaper innen helsesektoren. Fondet har som målsetting å skape god risikojustert avkastning over tid. Fondets midler blir investert i børsnoterte selskaper innen legemidler, bioteknologi, medisinsk utsyr og tjenester. Investeringer i fremmed valuta blir ikke valutasikret. For mer informasjon, se fondets prospekt.
    Read more

Investment horizon

  • Fondsfinans Global Helse B is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • NAV/Price

    10 Dec 2025

  • Margin rate
  • Start date
    22 May 2024
  • ISIN
    NO0013168740

Risk

  • Medium (4 of 7)

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

Annual cost

  • Ongoing costs

    Includes management fees of 0,70 %

  • Platform fee
  • Kickback fee
  • Annual running costs

Other costs

  • Performance-based fee
  • Transaction costs

  • Costs for any currency exchanges are not included.

Allocation

  • Stocks 99%
    Interest 1%

Portfolio

Shows the fund's largest investments.

  • UnitedHealth Group Inc
    6.4%
  • Roche Holding AG
    6.0%
  • AbbVie Inc
    5.9%
  • Eli Lilly and Co
    5.8%
  • Novartis AG Registered Shares
    5.3%
  • Gilead Sciences Inc
    4.4%
  • GSK PLC ADR
    4.1%
  • Abbott Laboratories
    4.1%
  • United Therapeutics Corp
    3.8%
  • Johnson & Johnson
    3.8%